Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: Relevance to Parkinson disease

Molecular and Cellular Proteomics

Volumn 5, Issue 7, 2006, Pages 1193-1204

  Jin, Jinghua ^a   Hulette, Christine ^b   Wang, Yan ^a   Zhang, Terry ^c   Pan, Catherine ^a   Wadhwa, Renu ^d   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Thermo Fisher Scientific   (United States)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; MORTALIN; PROTEASOME; UNCLASSIFIED DRUG;

ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA;

EID: 33746296891     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500382-MCP200     Document Type: Article

References (50)

1. Lowe, J. S., and Leigh, N. (2002) in Greenfield's Neuropathology (Graham, D. I., and Lantos, P. L., eds) pp. 325-430, Arnold, London
2. McNaught, K. S., Olanow, C. W., Halliwell, B., Isacson, O., and Jenner, P. (2001) Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2, 589-594
3. Owen, A. D., Schapira, A. H., Jenner, P., and Marsden, C. D. (1996) Oxidative stress and Parkinson's disease. Ann. N. Y. Acad. Sci. 786, 217-223
4. Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980
5. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306
6. McNaught, K. S., Perl, D. P., Brownell, A. L., and Olanow, C. W. (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann. Neurol. 56, 149-162
7. Kim, D. W. (2004) Efficient induction of dopaminergic neurons from embryonic stem cells for application to Parkinson's disease. Yonsei Med. J 45, (suppl.) 23-27
8. Ogawa, N. (1998) Early introduction of dopamine agonists in the long-term treatment of Parkinson's disease. Neurology 51, S13-20
9. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., and Yates, J. R., III (1999) Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17, 676-682
10. Zhou, Y., Wang, Y., Kovacs, M. I., Jin, J., and Zhang, J. (2005) Microglial activation induced by neurodegeneration. A proteomic analysis. Mol. Cell. Proteomics 4, 1471-1479
11. Zhou, Y., Gu, G., Goodlett, D. R., Zhang, T., Pan, C., Montine, T. J., Montine, K. S., Aebersold, R. H., and Zhang, J. (2004) Analysis of α-synuclein-associated proteins by quantitative proteomics. J. Biol. Chem. 279, 39155-39164
12. Michotte, A. (2003) Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism. Acta Neurol. Belg. 103, 155-158
13. Zhang, J., Montine, T. J., Smith, M. A., Siedlak, S. L., Gu, G., Robertson, D., and Perry, G. (2002) The mitochondrial common deletion in Parkinson's disease and related movement disorders. Parkinsonism Relat. Disord. 8, 165-170
14. Zhang, J., Perry, G., Smith, M. A., Robertson, D., Olson, S. J., Graham, D. G., and Montine, T. J. (1999) Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154, 1423-1429
15. Krapfenbauer, K., Fountoulakis, M., and Lubec, G. (2003) A rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractions. Electrophoresis 24, 1847-1870
16. Jin, J., Meredith, G. E., Chen, L., Zhou, Y., Xu, J., Shie, F. S., Lockhart, P., and Zhang, J. (2005) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol. Brain Res. 134, 119-138
17. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999
18. Zhang, J., Goodlett, D. R., Peskind, E. R., Quinn, J. F., Zhou, Y., Wang, Q., Pan, C., Yi, E., Eng, J., Aebersold, R. H., and Montine, T. J. (2005) Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol. Aging 26, 207-227
19. Zhang, J., Goodlett, D. R., Quinn, J. F., Peskind, E., Kaye, J. A., Zhou, Y., Pan, C., Yi, E., Eng, J., Wang, Q., Aebersold, R. H., and Montine, T. J. (2005) Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J. Alzheimer's Dis. 7, 125-133
20. Chelius, D., Zhang, T., Wang, G., and Shen, R. F. (2003) Global protein identification and quantification technology using two-dimensional liquid chromatography nanospray mass spectrometry. Anal. Chem. 75, 6658-6665
21. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392
22. Keller, A., Purvine, S., Nesvizhskii, A. I., Stolyar, S., Goodlett, D. R., and Kolker, E. (2002) Experimental protein mixture for validating tandem mass spectral analysis. Omics 6, 207-212
23. Li, X. J., Zhang, H., Ranish, J. A., and Aebersold, R. (2003) Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal. Biochem. 75, 6648-6657
24. Crawford, G. C., Le, W., Smith, R. G., Xie, W. J., Stefani, E., and Appel, S. H. (1992) A novel N18TG2X mesencephalon cell hybrid express properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neuorsci. 12, 3392-3398
25. Zhang, J., Price, J. O., Graham, D. G., and Montine, T. J. (1998) Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures. Biochem. Biophys. Res. Commun. 248, 812-816
26. Zhang, J., Kravtsov, V., Amarnath, V., Picklo, M. J., Graham, D. G., and Montine, T. J. (2000) Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. J. Neurochem. 74, 970-978
27. Kinter, M., and Sherman, N. E. (2002) Protein Sequencing and Identification Using Tandem Mass Spectrometry, pp. 152-160, John Wiley & Sons, New York
28. Jacobsen, L. B., Calvin, S. A., Colvin, K. E., and Wright, M. (2004) FuGENE 6 Transfection Reagent: the gentle power. Methods 33, 104-112
29. Zhang, J., Fitsanakis, V. A., Gu, G., Jing, D., Ao, M., Amamath, V., and Montine, T. J. (2003) Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J. Neurochem. 84, 336-346
30. McNaught, K. S., and Jenner, P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191-194
31. Beal, M. F. (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N. Y. Acad. Sci. 991, 120-131
32. Fiskum, G., Starkov, A., Polster, B. M., and Chinopoulos, C. (2003) Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann. N. Y. Acad. Sci. 991, 111-119
33. Dauer, W., and Przedborski, S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889-909
34. Benecke, R., Strumper, P., and Weiss, H. (1993) Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 116, 1451-1463
35. Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., and Shults, C. W. (1995) Low platelet mitochondrial complex I and complex II/ III activity in early untreated Parkinson's disease. Ann. Neurol. 37, 714-722
36. Simon, D. K., Mayeux, R., Marder, K., Kowall, N. W., Beal, M. F., and Johns, D. R. (2000) Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurology 54, 703-709
37. Schapira, A. H., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., and Marsden, C. D. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269
38. Wadhwa, R., Taira, K., and Kaul, S. C. (2002) An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? Cell Stress Chaperones 7, 309-316
39. Sherer, T. B., Kim, J. H., Betarbet, R., and Greenamyre, J. T. (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp. Neurol. 179, 9-16
40. Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., and Greenamyre, J. T. (2002) An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alphasynuclein metabolism and oxidative damage. J. Neurosci. 22, 7006-7015
41. Amanchy, R., Kalume, D. E., and Pandey, A. (2005) Stable isotope labeling with amino acids in cell culture (SILAC) for studying dynamics of protein abundance and posttranslational modifications. Sci. STKE 2005, pl2
42. Hoglinger, G. U., Carrard, G., Michel, P. P., Medja, F., Lombes, A., Ruberg, M., Friguet, B., and Hirsch, E. C. (2003) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J. Neurochem. 86, 1297-1307
43. Carr, S., Aebersold, R., Baldwin, M., Burlingame, A., Clauser, K., and Nesvizhskii, A. (2004) The need for guidelines in publication of peptide and protein identification data. Working Group on Publication Guidelines for Peptide and Protein Identification Data. Mol. Cell. Proteomics 3, 531-533
44. Wadhwa, R., Takano, S., Kaur, K., Aida, S., Yaguchi, T., Kaul, Z., Hirano, T., Taira, K., and Kaul, S. C. (2005) Identification and characterization of molecular interactions between mortalin/mthsp70 and hsp60. Biochem. J. 391, 185-190
45. Kaul, S. C., Duncan, E. L., Englezou, A., Takano, S., Reddel, R. R., Mitsui, Y., and Wadhwa, R. (1998) Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein. Oncogene 17, 907-911
46. Kaul, S. C., Yaguchi, T., Taira, K., Reddel, R. R., and Wadhwa, R. (2003) Overexpressed mortalin (mot-2)/mthsp70/GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts. Exp. Cell Res. 286, 96-101
47. Dundas, S. R., Lawrie, L. C., Rooney, P. H., and Murray, G. I. (2005) Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J. Pathol. 205, 74-81
48. Wadhwa, R., Takano, S., Taira, K., and Kaul, S. C. (2004) Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells. J. Gene Med. 6, 439-444
49. Kumazaki, T., Wadhwa, R., Kaul, S. C., and Mitsui, Y. (1997) Expression of endothelin, fibronectin, and mortalin as aging and mortality markers. Exp. Gerontol. 32, 95-103
50. Choi, J., Forster, M. J., McDonald, S. R., Weintraub, S. T., Carroll, C. A., and Gracy, R. W. (2004) Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease. Free Radic. Biol. Med. 36, 1155-1162